MATERNAL EXPOSURE DURING BREAST FEEDING

This adverse event was reported 4061 times

These drugs are most commonly taken by patients reporting MATERNAL EXPOSURE DURING BREAST FEEDING:

# Drug Count
0 CERTOLIZUMAB PEGOL 814
1 VEDOLIZUMAB 242
2 LAMOTRIGINE 204
3 LAMOTIRIGINE 181
4 LAMOTRIGINE CHEWABLE DISPERSIBLE 181
5 LAMOTRIGINE EXTENDED-RELEASE 181
6 PREDNISONE 175
7 FOLIC ACID 170
8 LEVETIRACETAM 160
9 DUPILUMAB 138
See all common drugs associated with MATERNAL EXPOSURE DURING BREAST FEEDING

MATERNAL EXPOSURE DURING BREAST FEEDING is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 C1 ESTERASE INHIBITOR RECOMBINANT 49 0.0076
1 INFLIXIMAB-DYYB 22 0.0064
2 OXYTOCIN 19 0.0062
3 METHYLDOPA 22 0.0045
4 HUMAN C1-ESTERASE INHIBITOR 64 0.0044
5 MESALAMINE 115 0.0041
6 IMIGLUCERASE 19 0.0040
7 LANADELUMAB-FLYO 12 0.0037
8 ERGOCALCIFEROL 107 0.0036
9 BRIVARACETAM 26 0.0028
See all drugs enriched for association with MATERNAL EXPOSURE DURING BREAST FEEDING